Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

BiOptimizers Magnesium Breakthrough capsules

Canada Type III Ongoing · initiated 2026-01-19

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Specialty Process Labs LLC

US Class II Ongoing · initiated 2026-01-16

Subpotent Drug

McKesson

US Class I Ongoing · initiated 2026-01-16

Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the …

Greenstone Llc

US Class II Ongoing · initiated 2026-01-15

Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information whe…

Amerisource Health Services LLC

US Class II Ongoing · initiated 2026-01-14

Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.

Octreotide for injectable suspension

Canada Type I Ongoing · initiated 2026-01-13

Product quality. If you have an affected product, do not use it. Speak to your health care professional immediately to obtain an alternative or replacement prod…

Teva Pharmaceuticals USA, Inc

US Class II Ongoing · initiated 2026-01-12

Superpotent and Subpotent

Teva Pharmaceuticals USA, Inc

US Class II Ongoing · initiated 2026-01-12

Superpotent and Subpotent